Report

albendazole market

Albendazole Market based on Target Pathogen (Tapeworm, Hookworm, Pinworm, and Others), End-use (Ascaris Infection Treatment, Pinworm Infection Treatment, and Others) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Veterinary Clinics) and Geography – Global Forecast up to 2026

pages Pages: 102
tables Tables: 108
charts Charts: 65
country Regions/Countries: 4 / 10
compaines Companies: 13
enqhours Enquiry Hours: 10
  • Get Free 10% Customization in this Report

COVID - 19

Covid impact updated reports at special price

Albendazole is a broad-range of antihelminthics. The primary method of action for albendazole is by its prohibitory consequence on tubulin polymerization, which leads to the loss of cytoplasmic microtubules. This drug is a medication taken for the treatment of a various number of parasitic worm infestations. It is very useful in conditions such as hydatid disease, giardiasis, filariasis, trichuriasis, neurocysticercosis, pinworm disease, and ascariasis, among others. The albendazole drug is taken orally. The albendazole market is majorly driven by key factors, including an increased incidences of worm infestations, specifically in the rural and developing areas. In addition to that, the lack of clean drinking water, hygiene, and absence of permitted sanitation in certain areas are the major reasons for the increasing number of parasitic worms which are eventually increasing the requirement of albendazole worldwide. On the other hand, the adverse impacts of the albendazole drugs such as nausea, headache, and bone marrow suppression, among others, are restricting the albendazole market growth. The Albendazole Market is projected to grow at the rate of 7.4% CAGR by 2026.

Research Methodology:

The albendazole market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

Albendazole Market

Albendazole Market based on Target Pathogen

  • Tapeworm
  • Hookworm
  • Pinworm
  • Others

 Albendazole Market based on End-use

  • Ascaris Infection Treatment
  • Pinworm Infection Treatment
  • Others

Albendazole Market based on Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Veterinary Clinics

Albendazole Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The market has been categorized into tapeworm, hookworm, pinworm, and others based on the target pathogen. The segment of ‘pinworm’ is expected to hold the major share in the market, owing to the high possibility of infection through pinworms, specifically in children, thereby increasing the demand for albendazole. Besides, the albendazole drug is considered effective medicine for killing pinworms.

Further, the market is segmented according to the end-user segment. The segmentation includes Ascaris infection treatment, pinworm infection treatment, and others. The pinworm infection treatment is estimated to dominate the albendazole market. This higher dominance can be attributed to the increasing incidence of pinworm infections worldwide, majorly in the underdeveloped areas where there is a lack of hygiene, inadequate drinking water, and lack of awareness about the importance of hygiene.

As per the market by distribution channel, the various distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and veterinary clinics. Online pharmacies are the significant distribution channel in the albendazole market due to the rising online purchases and the availability of various drugs in online pharmacies.

According to the market's regional penetration across the world, the North American region is holding the highest share in the albendazole market. This is ascribed to the increasing focus on research and development activities by key players in this region and the rising incidence of pinworm infections in the U.S.

Globally, the increasing prevalence of helminths infections which are caused by roundworm, hookworm, and other worms, is anticipated to boost the demand for anthelmintic drugs for infection treatment. This factor, in turn, will contribute to the growth of the global market. Moreover, the growing awareness regarding veterinary care raises the level of control and care of animals. This results in growth in the population of animals. Additionally, the improvements in veterinary education in the past few decades have placed greater importance on animal welfare, owing to which the demand for albendazole has increased in animal care. 

This report includes the key vendors operating in the market - Sequent Scientifi, Lasa Laboratory Pvt Ltd, CHANGZHOU YABANG, GlaxoSmithKline, MANAV DRUGS, Ashish life Science Pvt. Ltd., Huazhong Pharmaceutical, K.A.Malle Pharmaceuticals, HUBEI KEYI, Fredun Pharmaceuticals Ltd, Salius Pharma, Leo Bio-Care Pvt. and Hubei Zhongjia-chem pharmaceutical.

The albendazole drug has been considered as the safe and crucial medicine around the world, which is required for the health system. Moreover, few developing countries' governments are taking initiatives to tackle the increasing incidence of infectious diseases among rural areas.

  • The albendazole market report covers the trends such as the complete range of consumer trends and manufacturer trends
  • The report further focuses on the major market opportunities and challenges in the forecasted timeframe.
  • The report provides the Competitive outlook with analysis on competition pattern, portfolio comparisons, development trends, and strategic management
  • The report also entails the overall company profiles of the key players in the albendazole market
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Overview
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    4. DRO - Impact Analysis
  5. Target Pathogen: Market Size & Analysis
    1. Overview
    2. Tapeworm
    3. Hookworm
    4. Pinworm
    5. Others
  6.  End-Use: Market Size & Analysis
    1. Overview
    2. Ascaris Infection Treatment
    3. Pinworm Infection Treatment
    4. Others
  7. Distribution Channel: Market Size & Analysis
    1. Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies
    5. Veterinary Clinics
  8. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  9. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  10. Vendor Profiles
    1. Sequent Scientifi
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    2. Lasa Laboratory Pvt Ltd
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    3. CHANGZHOU YABANG
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    4. GlaxoSmithKline
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    5. MANAV DRUGS
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    6. Ashish life Science Pvt. Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    7. Huazhong Pharmaceutical
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    8. K.A.Malle Pharmaceuticals
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    9. HUBEI KEYI
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    10. Fredun Pharmaceuticals Ltd
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
  11. Companies to Watch
    1. Salius Pharma
      1. Overview
      2. Products & Services
      3. Business Strategy
    2. Leo Bio-Care Pvt.
      1. Overview
      2. Products & Services
      3. Business Strategy
    3. Hubei Zhongjia-chem Pharmaceutical
      1. Overview
      2. Products & Services
      3. Business Strategy
  12. Analyst Opinion
  13. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

TABLE 1.           GLOBAL ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 2.           GLOBAL ALBENDAZOLE MARKET VALUE FOR TAPEWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 3.           GLOBAL ALBENDAZOLE MARKET VALUE FOR HOOKWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 4.           GLOBAL ALBENDAZOLE MARKET VALUE FOR PINWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 5.           GLOBAL ALBENDAZOLE MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 6.           GLOBAL ALBENDAZOLE MARKET VALUE, BY END-USE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 7.           GLOBAL ALBENDAZOLE MARKET VALUE FOR ASCARIS INFECTION TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 8.           GLOBAL ALBENDAZOLE MARKET VALUE FOR PINWORM INFECTION TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 9.           GLOBAL ALBENDAZOLE MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 10.         GLOBAL ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 11.         GLOBAL ALBENDAZOLE MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 12.         GLOBAL ALBENDAZOLE MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 13.         GLOBAL ALBENDAZOLE MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 14.         GLOBAL ALBENDAZOLE MARKET VALUE FOR VETERINARY CLINICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 15.         NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 16.         NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 17.         NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 18.         NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 19.         U.S ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 20.         U.S ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 21.         U.S ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 22.         CANADA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 23.         CANADA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 24.         CANADA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 25.         EUROPE ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 26.         EUROPE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 27.         EUROPE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 28.         EUROPE ALBENDAZOLE MARKET VALUE, DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 29.         GERMANY ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 30.         GERMANY ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 31.         GERMANY ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 32.         U.K ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 33.         U.K ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 34.         U.K ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 35.         FRANCE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 36.         FRANCE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 37.         FRANCE ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 38.         ITALY ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 39.         ITALY ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 40.         ITALY ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 41.         SPAIN ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 42.         SPAIN ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 43.         SPAIN ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 44.         ROE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 45.         ROE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 46.         ROE ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 47.         ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)

TABLE 48.         ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 49.         ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 50.         ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 51.         CHINA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 52.         CHINA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 53.         CHINA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 54.         INDIA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 55.         INDIA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 56.         INDIA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 57.         JAPAN ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 58.         JAPAN ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 59.         JAPAN ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 60.         REST OF APAC ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 61.         REST OF APAC ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 62.         REST OF APAC ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 63.         REST OF WORLD ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)

TABLE 64.         REST OF WORLD ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)

TABLE 65.         REST OF WORLD ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)

TABLE 66.         SEQUENT SCIENTIFI: FINANCIALS       

TABLE 67.         SEQUENT SCIENTIFI: PRODUCT AND SERVICES           

TABLE 68.         SEQUENT SCIENTIFI: RECENT DEVELOPMENTS

TABLE 69.         SEQUENT SCIENTIFI: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 70.         LASA LABORATORY PVT LTD: FINANCIALS       

TABLE 71.         LASA LABORATORY PVT LTD: PRODUCT AND SERVICES           

TABLE 72.         LASA LABORATORY PVT LTD: RECENT DEVELOPMENTS

TABLE 73.         LASA LABORATORY PVT LTD: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 74.         CHANGZHOU YABANG: FINANCIALS     

TABLE 75.         CHANGZHOU YABANG: PRODUCT AND SERVICES         

TABLE 76.         CHANGZHOU YABANG: RECENT DEVELOPMENTS          

TABLE 77.         CHANGZHOU YABANG: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 78.         GLAXOSMITHKLINE: FINANCIALS         

TABLE 79.         GLAXOSMITHKLINE: PRODUCT AND SERVICES

TABLE 80.         GLAXOSMITHKLINE: RECENT DEVELOPMENTS 

TABLE 81.         GLAXOSMITHKLINE: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 82.         MANAV DRUGS: FINANCIALS   

TABLE 83.         MANAV DRUGS: PRODUCT AND SERVICES       

TABLE 84.         MANAV DRUGS: RECENT DEVELOPMENTS        

TABLE 85.         MANAV DRUGS: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 86.         ASHISH LIFE SCIENCE PVT. LTD: FINANCIALS 

TABLE 87.         ASHISH LIFE SCIENCE PVT. LTD: PRODUCT AND SERVICES     

TABLE 88.         ASHISH LIFE SCIENCE PVT. LTD: RECENT DEVELOPMENTS      

TABLE 89.         ASHISH LIFE SCIENCE PVT. LTD: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 90.         HUAZHONG PHARMACEUTICAL: FINANCIALS   

TABLE 91.         HUAZHONG PHARMACEUTICAL: PRODUCT AND SERVICES       

TABLE 92.         HUAZHONG PHARMACEUTICAL: RECENT DEVELOPMENTS        

TABLE 93.         HUAZHONG PHARMACEUTICAL: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 94.         K.A.MALLE PHARMACEUTICALS: FINANCIALS   

TABLE 95.         K.A.MALLE PHARMACEUTICALS: PRODUCT AND SERVICES       

TABLE 96.         K.A.MALLE PHARMACEUTICALS: RECENT DEVELOPMENTS        

TABLE 97.         K.A.MALLE PHARMACEUTICALS: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 98.         HUBEI KEYI: FINANCIALS        

TABLE 99.         HUBEI KEYI: PRODUCT AND SERVICES

TABLE 100.       HUBEI KEYI: RECENT DEVELOPMENTS 

TABLE 101.       HUBEI KEYI: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 102.       FREDUN PHARMACEUTICALS LTD: FINANCIALS

TABLE 103.       FREDUN PHARMACEUTICALS LTD: PRODUCT AND SERVICES    

TABLE 104.       FREDUN PHARMACEUTICALS LTD: RECENT DEVELOPMENTS     

TABLE 105.       FREDUN PHARMACEUTICALS LTD: APPLICATION/SERVICE PROVIDER PORTFOLIO

TABLE 106.       SALIUS PHARMA: PRODUCT AND SERVICES     

TABLE 107.       LEO BIO-CARE PVT: PRODUCT AND SERVICES 

TABLE 108.       HUBEI ZHONGJIA-CHEM PHARMACEUTICAL: PRODUCT AND SERVICES

Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting
Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

outicon

Albendazole Market based on Target Pathogen (Tapeworm, Hookworm, Pinworm, and Others), End-use (Ascaris Infection Treatment, Pinworm Infection Treatment, and Others) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Veterinary Clinics) and Geography – Global Forecast up to 2026
Interested in this report?
Get your FREE sample now!
DOWNLOAD NOW

Select User License

$
Request For Sample Report
Enquire Before Buying

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports
Card image cap
Genital Herpes Treatment Market by Type of Drugs (Acyclovir,...
$ 4000
Card image cap
Compounding Pharmacy Market by Therapeutic Areas (Hormone Re...
$ 4000
Card image cap
Attention Deficit Hyperactivity Market by Drug Type (Stimula...
$ 4000
Card image cap
Heparin Sales Market By Type (Low Molecular Weight Heparin, ...
$ 4000
Card image cap
Vaccine Market By Technology Type (Recombinant, Conjugate Va...
$ 4000
Card image cap
Yeast Infection Market based on Pathogen Type (Candida albic...
$ 4000